Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
49.53
+1.47 (3.06%)
At close: Jun 9, 2025, 4:00 PM
49.55
+0.02 (0.04%)
After-hours: Jun 9, 2025, 7:41 PM EDT
Guardant Health Stock Forecast
Stock Price Forecast
According to 20 professional analysts, the 12-month price target for Guardant Health stock ranges from a low of $35 to a high of $70. The average analyst price target of $53.85 forecasts a 8.72% increase in the stock price over the next year.
Price Target: $53.85 (+8.72%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 6, 2025.
Analyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 11 | 11 | 11 | 10 |
| Buy | 5 | 8 | 9 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 19 | 20 | 21 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $60 | Buy | Maintains | $50 → $60 | +21.14% | May 6, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $52 → $57 | Buy | Maintains | $52 → $57 | +15.08% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $60 → $65 | Strong Buy | Maintains | $60 → $65 | +31.23% | May 1, 2025 |
| Stifel | Stifel | Strong Buy Maintains $53 → $60 | Strong Buy | Maintains | $53 → $60 | +21.14% | May 1, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $60 | Buy | Maintains | $55 → $60 | +21.14% | May 1, 2025 |
Financial Forecast
Revenue This Year
910.18M
from 739.02M
Increased by 23.16%
Revenue Next Year
1.11B
from 910.18M
Increased by 21.40%
EPS This Year
-3.15
from -3.56
EPS Next Year
-2.69
from -3.15
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 934.6M | 1.2B | 1.6B | ||
| Avg | 910.2M | 1.1B | 1.4B | ||
| Low | 837.9M | 980.0M | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.5% | 31.6% | 48.6% | ||
| Avg | 23.2% | 21.4% | 23.4% | ||
| Low | 13.4% | 7.7% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.15 | -1.13 | -1.84 | ||
| Avg | -3.15 | -2.69 | -2.23 | ||
| Low | -3.39 | -2.99 | -2.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.